Vibriocidal antibody responses in North American volunteers exposed to wild-type or vaccine Vibrio cholerae O139: specificity and relevance to immunity.
about
A randomized, placebo-controlled trial of the bivalent killed, whole-cell, oral cholera vaccine in adults and children in a cholera endemic area in Kolkata, IndiaSynthetic fragments of Vibrio cholerae O1 Inaba O-specific polysaccharide bound to a protein carrier are immunogenic in mice but do not induce protective antibodiesConstitutive type VI secretion system expression gives Vibrio cholerae intra- and interspecific competitive advantages.Vibriocidal antibody responses to a bivalent killed whole-cell oral cholera vaccine in a phase III trial in Kolkata, IndiaVibrio cholerae O139 conjugate vaccines: synthesis and immunogenicity of V. cholerae O139 capsular polysaccharide conjugates with recombinant diphtheria toxin mutant in mice.Serum bactericidal assays to evaluate typhoidal and nontyphoidal Salmonella vaccines.Investigation of the roles of toxin-coregulated pili and mannose-sensitive hemagglutinin pili in the pathogenesis of Vibrio cholerae O139 infectionValidation and characterization of a human volunteer challenge model for cholera by using frozen bacteria of the new Vibrio cholerae epidemic serotype, O139Sensitive microplate assay for detection of bactericidal antibodies to Vibrio cholerae O139Susceptibility of Vibrio cholerae O139 to antibody-dependent, complement-mediated bacteriolysisReduction in capsular content and enhanced bacterial susceptibility to serum killing of Vibrio cholerae O139 associated with the 2002 cholera epidemic in BangladeshTranscutaneous immunization with a synthetic hexasaccharide-protein conjugate induces anti-Vibrio cholerae lipopolysaccharide responses in mice.Safety and immunogenicity of the killed bivalent (O1 and O139) whole-cell cholera vaccine in the Philippines.A randomized, observer-blinded, equivalence trial comparing two variations of Euvichol®, a bivalent killed whole-cell oral cholera vaccine, in healthy adults and children in the Philippines.Bivalent oral cholera vaccine in participants aged 1 year and older in the Dominican Republic: A phase III, single-arm, safety and immunogenicity trial
P2860
Q21144301-6ED4E541-16B4-484C-A1CC-0641251B37E5Q30341949-73A1FD84-98BA-4240-B5FA-0EF5AE3CDF79Q30422970-58978D87-F13D-4881-A55E-AB5A03C0E2A9Q33572955-3056D185-C297-4449-A14B-187C322AFF52Q33598485-0BD971A1-FA69-4C38-92C0-8F27D0D4A908Q33601858-515028E7-F5DF-495C-81B4-BD4D4AE83735Q33750441-D6383059-C3BB-4D99-BB9A-6ADA6F0D51EDQ33777947-F9A3F2D7-3DEC-46AD-9782-FA597DF1A2CDQ33942939-63DF8B45-5055-42C1-91B7-2707F0112B50Q33998373-8C5E8B13-9961-4351-B4A5-BA8EF625F5B0Q34033623-7152DB86-62CD-403E-BCBA-64DA2F0A6E4BQ37386803-226FFE27-5BE4-4AF0-9DC0-CB0F958D1997Q48344793-6FEA74E7-771B-41D2-A166-6FB45D653C34Q55500339-969ABF6B-D2B4-490B-9206-6CF168C1910AQ57940864-A4A09FAE-D2AB-41A7-89FA-3D8A908D88D3
P2860
Vibriocidal antibody responses in North American volunteers exposed to wild-type or vaccine Vibrio cholerae O139: specificity and relevance to immunity.
description
1997 nî lūn-bûn
@nan
1997 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
1997 թվականի մայիսին հրատարակված գիտական հոդված
@hy
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
name
Vibriocidal antibody responses ...... ity and relevance to immunity.
@ast
Vibriocidal antibody responses ...... ity and relevance to immunity.
@en
type
label
Vibriocidal antibody responses ...... ity and relevance to immunity.
@ast
Vibriocidal antibody responses ...... ity and relevance to immunity.
@en
prefLabel
Vibriocidal antibody responses ...... ity and relevance to immunity.
@ast
Vibriocidal antibody responses ...... ity and relevance to immunity.
@en
P2093
P2860
P1476
Vibriocidal antibody responses ...... ity and relevance to immunity.
@en
P2093
C O Tacket
G A Losonsky
J A Johnson
J G Morris
L E Comstock
M M Levine
P Motamedi
P2860
P304
P577
1997-05-01T00:00:00Z